ACORN BIOVENTURES, L.P. 13D and 13G filings for Candel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-30 09:55 am Purchase | 2025-06-25 | 13G | Candel Therapeutics, Inc. CADL | ACORN BIOVENTURES, L.P. | 2,580,517 5.200% | 2,580,517 (New Position) | Filing |